Abstract
For unknown reasons the incidence of non-Hodgkin’s Lymphomas (NHL) has increased during the last decades. Conditions with impaired immune functions have been associated with an increased risk of malignant lymphomas. Interactions between the central nervous, immune, and endocrine systems have been recently identified, and the potential physiological importance of these interactions is being explored. In this prospective cohort study the potential association between an increasing incidence of depressive disorders and the development of malignant lymphoma is being explored. The participants were part of the Swedish manpower on sick leave between 1988 and 2000 with depressive disease for more than two weeks were followed until a diagnosis of lymphoid malignancy, death, emigration, or end of follow-up period. The final cohort included 87,677 individuals with 373,135 years of follow-up. There were 80 cases of NHL, chronic lymphocytic leukemia (CLL), and Hodgkin lymphoma (HL) with 70 cases expected. The first year of follow-up showed a slightly increased risk of NHL, which most probably can be interpreted as initial symptoms of lymphoma. We conclude that the increase in the incidence of malignant lymphomas observed during the last decades seems not to be associated with a concurrent increase of depressive disorders.
Similar content being viewed by others
Abbreviations
- CLL:
-
chronic lymphocytic leukemia
- CI:
-
confidence interval
- HL:
-
Hodgkin lymphoma
- NHL:
-
non-Hodgkin’s lymphoma
- SSRI:
-
selective serotonin reuptake inhibitor
- SIR:
-
standardised incidence ratio
References
Asberg M, Håkansson I, Hagberg B, Henriksson I, Kimbré S. Treatment of depression – a systematic review: The Swedish Council on Technology Assessment in Health care, 2004.
RM Hirschfeld MB Keller S Panico et al. (1997) ArticleTitleThe National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression Jama 277 IssueID4 333–340 Occurrence Handle10.1001/jama.277.4.333 Occurrence Handle9002497
SP Palsson S Ostling I Skoog (2001) ArticleTitleThe incidence of first-onset depression in a population followed from the age of 70 to 85 Psychol Med 31 IssueID7 1159–1168 Occurrence Handle10.1017/S0033291701004524 Occurrence Handle11681542
P Allebeck (1989) ArticleTitleSchizophrenia: A life-shortening disease Schizophr Bull 15 IssueID1 81–89 Occurrence Handle2717890
P Jorgensen PB Mortensen (1992) ArticleTitleCause of death in reactive psychosis Acta Psychiatr Scand 85 IssueID5 351–353 Occurrence Handle1605055
MT Tsuang RF Woolson JA Fleming (1980) ArticleTitleCauses of death in schizophrenia and manic-depression Br J Psychiatry 136 239–242 Occurrence Handle7388226
LR Wulsin GE Vaillant VE Wells (1999) ArticleTitleA systematic review of the mortality of depression Psychosom Med 61 IssueID1 6–17 Occurrence Handle10024062
B Leonard (1987) ArticleTitleStress, the immune system and mental illness Stress Med 3 257–258
Vose JM, Chiu BC, Cheson BD, Dancey J, Wright J. Update on epidemiology and therapeutics for non-Hodgkin’s lymphoma. Hematology (Am Soc Hematol Educ Program) 2002: 241–262.
D Baris SH Zahm (2000) ArticleTitleEpidemiology of lymphomas Curr Opin Oncol 12 IssueID5 383–394 Occurrence Handle10.1097/00001622-200009000-00002 Occurrence Handle10975544
CA Clarke SL Glaser (2002) ArticleTitleChanging incidence of non-Hodgkin lymphomas in the United States Cancer 94 IssueID7 2015–2023 Occurrence Handle10.1002/cncr.10403 Occurrence Handle11932904
H Brincker NT Pedersen K Bendix-Hansen P Johansen (2000) ArticleTitleNon-Hodgkin’s lymphoma subtypes over time in an unselected population of 646 patients: A study of clinico-pathological data and incidence based on a review using the REAL-classification Leuk Lymphoma 39 IssueID5–6 531–541 Occurrence Handle11342336
L Bjornadal B Lofstrom L Yin IE Lundberg A Ekbom (2002) ArticleTitleIncreased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus Scand J Rheumatol 31 IssueID2 66–71 Occurrence Handle10.1080/03009740252937568 Occurrence Handle12109649
M Zeier W Hartschuh M Wiesel T Lehnert E Ritz (2002) ArticleTitleMalignancy after renal transplantation Am J Kidney Dis 39 IssueID1 E5 Occurrence Handle11774131
J Cibere J Sibley M Haga (2001) ArticleTitleSystemic lupus erythematosus and the risk of malignancy Lupus 10 IssueID6 394–400 Occurrence Handle10.1191/096120301678646128 Occurrence Handle11434573
O Kirk C Pedersen A Cozzi-Lepri et al. (2001) ArticleTitleNon-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy Blood 98 IssueID12 3406–3412 Occurrence Handle10.1182/blood.V98.12.3406 Occurrence Handle11719381
J Kaye J Morton M Bowcutt D Maupin (2000) ArticleTitleStress, depression, and psychoneuroimmunology J Neurosci Nurs 32 IssueID2 93–100 Occurrence Handle10826295
JK Kiecolt-Glaser R Glaser (1999) ArticleTitlePsychoneuroimmunology and cancer: Fact or fiction? Eur J Cancer 35 IssueID11 1603–1607 Occurrence Handle10.1016/S0959-8049(99)00197-5 Occurrence Handle10673969
AH Miller RL Spencer BS McEwen M Stein (1993) ArticleTitleDepression, adrenal steroids, and the immune system Ann Med 25 IssueID5 481–487 Occurrence Handle8251149
J Gordon NM Barnes (2003) ArticleTitleLymphocytes transport serotonin and dopamine: Agony or ecstasy? Trends Immunol 24 IssueID8 438–443 Occurrence Handle10.1016/S1471-4906(03)00176-5 Occurrence Handle12909457
B Mattsson A Wallgren (1984) ArticleTitleCompleteness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978 Acta Radiol Oncol 23 IssueID5 305–313 Occurrence Handle6095600
AS Lunde S Lundeborg GS Lettenstrom L Thygesen J Huebner (1980) ArticleTitleThe person-number systems of Sweden, Norway, Denmark, and Israel Vital Health Stat 2 2 IssueID84 1–59
GA Kaplan P Reynolds (1988) ArticleTitleDepression and cancer mortality and morbidity: Prospective evidence from the Alameda County study J Behav Med 11 IssueID1 1–13 Occurrence Handle10.1007/BF00846165 Occurrence Handle3367368
RW Linkins GW Comstock (1990) ArticleTitleDepressed mood and development of cancer Am J Epidemiol 132 IssueID5 962–972 Occurrence Handle2239911
R McGee S Williams M Elwood (1994) ArticleTitleDepression and the development of cancer: A meta-analysis Soc Sci Med 38 IssueID1 187–192 Occurrence Handle10.1016/0277-9536(94)90314-X Occurrence Handle8146710
BW Penninx JM Guralnik M Pahor et al. (1998) ArticleTitleChronically depressed mood and cancer risk in older persons J Natl Cancer Inst 90 IssueID24 1888–1893 Occurrence Handle10.1093/jnci/90.24.1888 Occurrence Handle9862626
RB Shekelle WJ Raynor SuffixJr AM Ostfeld et al. (1981) ArticleTitlePsychological depression and 17-year risk of death from cancer Psychosom Med 43 IssueID2 117–125 Occurrence Handle7267935
AB Zonderman PT Costa SuffixJr RR McCrae (1989) ArticleTitleDepression as a risk for cancer morbidity and mortality in a nationally representative sample Jama 262 IssueID9 1191–1195 Occurrence Handle10.1001/jama.262.9.1191 Occurrence Handle2761060
SO Dalton C Johansen L Mellemkjaer et al. (2000) ArticleTitleAntidepressant medications and risk for cancer Epidemiology 11 IssueID2 171–176 Occurrence Handle10.1097/00001648-200003000-00015 Occurrence Handle11021615
S Bahl M Cotterchio N Kreiger N Klar (2004) ArticleTitleAntidepressant medication use and non-Hodgkin’s lymphoma risk: No association Am J Epidemiol 160 IssueID6 566–575 Occurrence Handle10.1093/aje/kwh234 Occurrence Handle15353417
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nordström, M., Granath, F., Björkholm, M. et al. Sick Leave due to Depressive Disease: Not a Risk Factor for the Development of Malignant Lymphoma. Eur J Epidemiol 20, 769–773 (2005). https://doi.org/10.1007/s10654-005-1050-7
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10654-005-1050-7